U
CELG

UBS’s Celgene Corp CELG Stock Holding History

UBS’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6.11M Buy
64,500
+300
+0.5% +$27.1K ﹤0.01% 1841
2014
Q2 		$5.51M Buy
64,200
+3,400
+6% +$259K ﹤0.01% 1871
2014
Q1 		$4.24M Sell
60,800
-67,800
-53% -$5.37M ﹤0.01% 2020
2013
Q4 		$10.9M Buy
128,600
+50,400
+64% +$3.99M 0.01% 1194
2013
Q3 		$6.03M Sell
78,200
-37,600
-32% -$2.64M 0.01% 1556
2013
Q2 		$6.77M Buy
+115,800
New +$6.97M 0.01% 1348

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

UBS's CELG Position: Q3 2014 in Review

UBS increased its Celgene Corp (CELG) stake by 17% in Q3 2014, buying an estimated $44.3M and bringing the position to 3,396,963 shares worth $322M. The position accounts for 0.24% of the portfolio, ranked #81.

UBS first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • UBS held 3,396,963 shares of Celgene Corp worth $322M as of Q3 2014.
  • UBS bought 490,488 Celgene Corp shares in Q3 2014, an estimated $44.3M.
  • Celgene Corp made up 0.24% of UBS's portfolio in Q3 2014, its #81 holding.
  • UBS first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.